Compounding pharmacies rebut Novo’s FDA petition

The Alliance for Pharmacy Compounding rebutted Novo's FDA petition to bar compounding pharmacies from copying its weight loss drug semaglutide, saying Novo “disingenuously asserts” that compounded versions are unsafe and…